Toggle light / dark theme

Pilot Study of Fingolimod Treatment in Neuronal Ceroid Lipofuscinosis Type 1

The findings in this study demonstrate that reduced neurofilament light chain levels suggest decreased neuroaxonal damage associated with immune modulation, supporting its potential role in targeting inflammatory processes in CLN1 without fully halting disease progression.


Background and Objectives.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.

/* */